Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
37
MDAI Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
-17.09%
Day range:
$1.63 - $1.75
52-week range:
$1.04 - $3.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.68x
P/B ratio:
--
Volume:
412.1K
Avg. volume:
488.2K
1-year change:
-18.72%
Market cap:
$50.6M
Revenue:
$29.6M
EPS (TTM):
-$0.75
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
|
$5M | -$0.09 | -61.78% | -70.85% | $5.09 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$806.3K | -$0.04 | 272.5% | -33.67% | $2.60 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$28.5M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
|
$1.65 | $5.09 | $50.6M | -- | $0.00 | 0% | 1.68x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
VTAK
Catheter Precision, Inc.
|
$2.38 | -- | $2.9M | 0.40x | $0.00 | 0% | 11.19x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
|
661.08% | 3.126 | 15.56% | 0.73x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MDAI
Spectral AI, Inc.
|
$1.5M | -$3.3M | -727.59% | -4727.7% | -88.11% | -$2.5M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Spectral AI, Inc. vs. Competitors
-
Which has Higher Returns MDAI or CATX?
Perspective Therapeutics, Inc. has a net margin of -93.67% compared to Spectral AI, Inc.'s net margin of -12425.36%. Spectral AI, Inc.'s return on equity of -4727.7% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital MDAISpectral AI, Inc.38.24% -$0.14 $1.5M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About MDAI or CATX?
Spectral AI, Inc. has a consensus price target of $5.09, signalling upside risk potential of 225%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than Spectral AI, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Spectral AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MDAISpectral AI, Inc.2 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is MDAI or CATX More Risky?
Spectral AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock MDAI or CATX?
Spectral AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spectral AI, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDAI or CATX?
Spectral AI, Inc. quarterly revenues are $3.8M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Spectral AI, Inc.'s net income of -$3.6M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Spectral AI, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spectral AI, Inc. is 1.68x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDAISpectral AI, Inc.1.68x -- $3.8M -$3.6M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns MDAI or PMI?
Picard Medical has a net margin of -93.67% compared to Spectral AI, Inc.'s net margin of --. Spectral AI, Inc.'s return on equity of -4727.7% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MDAISpectral AI, Inc.38.24% -$0.14 $1.5M PMIPicard Medical-- -- -- -
What do Analysts Say About MDAI or PMI?
Spectral AI, Inc. has a consensus price target of $5.09, signalling upside risk potential of 225%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Spectral AI, Inc. has higher upside potential than Picard Medical, analysts believe Spectral AI, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings MDAISpectral AI, Inc.2 0 0 PMIPicard Medical0 0 0 -
Is MDAI or PMI More Risky?
Spectral AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MDAI or PMI?
Spectral AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spectral AI, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDAI or PMI?
Spectral AI, Inc. quarterly revenues are $3.8M, which are larger than Picard Medical quarterly revenues of --. Spectral AI, Inc.'s net income of -$3.6M is higher than Picard Medical's net income of --. Notably, Spectral AI, Inc.'s price-to-earnings ratio is -- while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spectral AI, Inc. is 1.68x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDAISpectral AI, Inc.1.68x -- $3.8M -$3.6M PMIPicard Medical-- -- -- --
-
Which has Higher Returns MDAI or VNRX?
VolitionRX Ltd. has a net margin of -93.67% compared to Spectral AI, Inc.'s net margin of -862.39%. Spectral AI, Inc.'s return on equity of -4727.7% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MDAISpectral AI, Inc.38.24% -$0.14 $1.5M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About MDAI or VNRX?
Spectral AI, Inc. has a consensus price target of $5.09, signalling upside risk potential of 225%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than Spectral AI, Inc., analysts believe VolitionRX Ltd. is more attractive than Spectral AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MDAISpectral AI, Inc.2 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is MDAI or VNRX More Risky?
Spectral AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock MDAI or VNRX?
Spectral AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spectral AI, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDAI or VNRX?
Spectral AI, Inc. quarterly revenues are $3.8M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Spectral AI, Inc.'s net income of -$3.6M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Spectral AI, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spectral AI, Inc. is 1.68x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDAISpectral AI, Inc.1.68x -- $3.8M -$3.6M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns MDAI or VTAK?
Catheter Precision, Inc. has a net margin of -93.67% compared to Spectral AI, Inc.'s net margin of -1037.17%. Spectral AI, Inc.'s return on equity of -4727.7% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital MDAISpectral AI, Inc.38.24% -$0.14 $1.5M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About MDAI or VTAK?
Spectral AI, Inc. has a consensus price target of $5.09, signalling upside risk potential of 225%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Spectral AI, Inc., analysts believe Catheter Precision, Inc. is more attractive than Spectral AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MDAISpectral AI, Inc.2 0 0 VTAKCatheter Precision, Inc.0 0 0 -
Is MDAI or VTAK More Risky?
Spectral AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock MDAI or VTAK?
Spectral AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spectral AI, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDAI or VTAK?
Spectral AI, Inc. quarterly revenues are $3.8M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Spectral AI, Inc.'s net income of -$3.6M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Spectral AI, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spectral AI, Inc. is 1.68x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDAISpectral AI, Inc.1.68x -- $3.8M -$3.6M VTAKCatheter Precision, Inc.11.19x 0.40x $226K -$2.3M
-
Which has Higher Returns MDAI or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -93.67% compared to Spectral AI, Inc.'s net margin of 3.93%. Spectral AI, Inc.'s return on equity of -4727.7% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital MDAISpectral AI, Inc.38.24% -$0.14 $1.5M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About MDAI or XTNT?
Spectral AI, Inc. has a consensus price target of $5.09, signalling upside risk potential of 225%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Spectral AI, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Spectral AI, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MDAISpectral AI, Inc.2 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is MDAI or XTNT More Risky?
Spectral AI, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock MDAI or XTNT?
Spectral AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spectral AI, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MDAI or XTNT?
Spectral AI, Inc. quarterly revenues are $3.8M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Spectral AI, Inc.'s net income of -$3.6M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Spectral AI, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spectral AI, Inc. is 1.68x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDAISpectral AI, Inc.1.68x -- $3.8M -$3.6M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is down 6.09% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 57.53% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 9.88% over the past day.
